These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36718149)

  • 1. Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in China.
    Sun Y; Wang M; Lin W; Dong W; Xu J
    J Biosaf Biosecur; 2023 Mar; 5(1):14-20. PubMed ID: 36718149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance and Analysis of SARS-CoV-2 Variant Importation - China, January-June 2022.
    Feng Y; Zhao X; Yin Z; Wu C; Chen Z; Nie K; A R; Li L; Niu P; Wang J; Wu Y; Wang S; Wang D; Tan W; Wang H; Ma X; Gao GF; Chen C; Xu W
    China CDC Wkly; 2022 Dec; 4(50):1136-1142. PubMed ID: 36751558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
    Pan Y; Wang L; Feng Z; Xu H; Li F; Shen Y; Zhang D; Liu WJ; Gao GF; Wang Q
    Lancet; 2023 Feb; 401(10377):664-672. PubMed ID: 36773619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Surveillance for SARS-CoV-2 - China, September 26, 2022 to January 29, 2023.
    Wang S; Niu P; Su Q; He X; Tang J; Wang J; Feng Y; Chen C; Zhao X; Chen Z; Wang W; Yin Z; Wu Y; Wu C; Li L; Cui A; Zhang Y; Long C; Yang X; Zhang Z; Bo H; Xu W; Sars-CoV-Genome Working Group
    China CDC Wkly; 2023 Feb; 5(7):143-151. PubMed ID: 37009519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of incubation periods of infections of Omicron variants BA.2 and BF.7 in Beijing].
    Xu X; Cai YX; Liu YH; Shen Y; Pan Y; Yao H; Wang XL; Yang P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Sep; 44(9):1397-1401. PubMed ID: 37743272
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk evaluation and mitigation strategies for newly detected SARS-CoV-2 Omicron BF.7 subvariant: A brief report.
    Nazmunnahar ; Ahmed I; Islam MR
    Health Sci Rep; 2023 Mar; 6(3):e1127. PubMed ID: 36875932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan.
    Jin B; Oyama R; Tabe Y; Tsuchiya K; Hando T; Wakita M; Yan Y; Saita M; Takei S; Horiuchi Y; Miida T; Naito T; Takahashi K; Ogawa H
    Front Microbiol; 2023; 14():1229234. PubMed ID: 37744926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
    Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
    JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
    Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
    Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China.
    Zhang M; Chen Z; Zhou J; Zhao X; Chen Y; Sun Y; Liu Z; Gu W; Luo C; Fu X; Zhao X
    Biosaf Health; 2022 Dec; 4(6):406-409. PubMed ID: 36320663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022.
    Novazzi F; Giombini E; Rueca M; Baj A; Fabeni L; Genoni A; Ferrante FD; Gramigna G; Gruber CEM; Boutahar S; Minosse C; Butera O; Pasciuta R; Focosi D; Colombo A; Antinori A; Girardi E; Vaia F; Maggi F
    Euro Surveill; 2023 Jan; 28(2):. PubMed ID: 36695479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current surge of COVID-19 infection in China and its impact on India.
    Gupta E; Samal J; Gautam P; Agarwal R
    Indian J Med Microbiol; 2023; 42():46-48. PubMed ID: 36967215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
    Xia S; Wang L; Zhu Y; Lu L; Jiang S
    Signal Transduct Target Ther; 2022 Jul; 7(1):241. PubMed ID: 35853878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2: Searching for the Missing Variants.
    Caputo E; Mandrich L
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China.
    Zhu W; Wang X; Lin Y; He L; Zhang R; Wang C; Zhu X; Tang T; Gu L
    Front Public Health; 2023; 11():1273745. PubMed ID: 38106899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Evolution and Early Introductions of the SARS-CoV-2 Omicron Variant in Mexico.
    Castelán-Sánchez HG; Martínez-Castilla LP; Sganzerla-Martínez G; Torres-Flores J; López-Leal G
    Virus Evol; 2022; 8(2):veac109. PubMed ID: 36582501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.